期刊文献+

布替萘芬霜剂局部给药对家兔慢性毒性实验研究 被引量:1

Experimental Study on the Chronic Toxicity of Butenafine Cream Local Delivery in Rabbits
下载PDF
导出
摘要 目的 :观察布替萘芬霜剂长期大剂量皮肤局部使用对家兔的慢性毒性作用。方法 :将 2 4只家兔随机分成 4组 :对照组、布替萘芬高 (2 0 % )、中 (10 % )、低 (5 % )剂量组 ,连续皮肤局部使用 1个月后 ,进行全身情况、血液学、血液生化、组织学检查。结果 :除敷药的局部皮肤有些异常外 ,实验组家兔全身情况、血液学参数、血液生化指标、组织学检查与对照组相比均无明显差异。结论 :布替萘芬局部给药安全 ,临床应用可靠。 Objective: To observe the chronic toxic effect of butenafine (BT) cream local delivery in rabbits with large dose and long term administration. Methods: 24 rabbits were divided randomly into four groups: control group (with drug free cream), BT high dosage group (20%), BT middle dosage group (10%) and low dosage group (5%). After 1 month continue local drug delivery in rabbits, the systemic condition, hematology, serum biochemistry and histology of rabbits were measured. Results: There were no significant differences in the systemic condition, hematology, serum biochemistry and histology between experimental and control group, except for light abnormity of local skin. Conclutions: Butenafine can be safely local used in clinical trial.
出处 《江苏大学学报(医学版)》 CAS 2002年第3期220-222,共3页 Journal of Jiangsu University:Medicine Edition
关键词 实验研究 布替萘芬 慢性毒性 家兔 局部给药 Butenafine Chronic toxicity Rabbit Local drug delivery
  • 相关文献

参考文献6

  • 1虞瑞尧.外用抗真菌药布替萘芬治疗浅部真菌病[J].国外医学(皮肤性病学分册),1999,25(5):300-302. 被引量:2
  • 2药事研究会.最近的新药[J].月刊药事(日文),1992,34(6):187-187.
  • 3Arika T, Yokoo M, Yamaguchi H. Topical treatment with butenafine significantly lowers relapse rate in an interdigital tinea pedis model in guinea pigs[J]. Antimicrob Agents Chemother, 1992, 36(11) :2523 - 2525.
  • 4Savin R, De Villez RL, Elewski B, et al. One-week therapy with twice-daily butenafine 1% cream versus vehicle in the treatment of tinea pedis: a multicenter double-blind trial[J].J Am Acad Dermatol, 1997, 36(2 part 1):15- 19.
  • 5Mcneely W, Spencer CM. Butenafine[J]. Drugs, 1998,55(3) :405 - 412.
  • 6Lesher JL Jr, Babel DE, Steward DM, et al. Butenafine 1% cream in the treatment of tinea cruris: a multicenter vehiclecontrolled, double-blind trial [J]. J Am Acad Dermatol,1997,36(2 part 1) :20 -24.

共引文献1

同被引文献7

  • 1Nahm WK,Orengo I,Rosen T.The antifungal agent butenafine manifests anti-inflammatory activity in vivo[J].J Am Acad Dermatol,1999,41 (2 pt 1):203 -206.
  • 2徐淑云,卞如濂,陈修.药理实验方法学[M].3版.北京:人民卫生出版社,2001:882-915.
  • 3Heller A,Koch T,Schmech J,et al.Lipid mediator in inflammatory disorders[J].Drugs,1998,55 (4):487 -496.
  • 4Gupta AK,Einarson TR,Summerbell RC,et al.An overview of topical amtifungal therapy in dermatomycoses.A North American perspeetive[J].Drugs,1998,55(5):645 -674.
  • 5Iwatani W,Arika T,Yamaguchi H.Two mechanisms of butenafine action in Candida albicans[J].Antimicrob Agents Chemother,1993,37 (4):785-788.
  • 6王爱平,李若瑜,杨海珍,万哲,陈伟,朱学骏.1%盐酸布替萘芬溶液治疗趾间型足癣和体股癣随机双盲对照临床试验[J].中国临床药理学杂志,2001,17(5):344-347. 被引量:10
  • 7张晓东,刘元林,凌云,鲍燕燕.1%布替萘芬霜和复方布替萘芬霜治疗足癣的临床观察[J].中国皮肤性病学杂志,2001,15(6):383-384. 被引量:9

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部